NCT04541771.

Study name	The role of Lactobacillus reuteri in preventing necrotizing enterocolitis (NEC) in pre‐term infants (NEC)
Methods	RCT
Participants	Preterm infants (28 to 34 weeks')
Interventions	Lactobacillus reuteri until 35 weeks' of gestation or discharged from hospital
Outcomes	NEC, infection
Starting date	2020
Contact information	Dr Summera Tabasum, The Children Complex & The Institute of Child Health, Multan
Notes	ClinicalTrials.gov identifier: NCT04541771

NEC: necrotising enterocolitis; RCT: randomised controlled trial; VLBW: very low birth weight